SEARCH

SEARCH BY CITATION

References

  • Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263265.
  • Beecham, G. W., Martin, E. R., Li, Y. J., Slifer, M.A., Gilbert, J.R., Haines, J.L. & Pericak-Vance, M.A. (2009) Genome-wide association study implicates a chromosome 12 risk locus for late-onset alzheimer disease. Am J Hum Genet 84, 3543.
  • Burne, T. H., McGrath, J. J., Eyles, D. W. & Mackay-Sim, A. (2005) Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 157, 299308.
  • Chan, C. S., Gertler, T. S. & Surmeier, D. J. (2009) Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci 32, 249256.
  • Deluca, H. F. & Cantorna, M. T. (2001) Vitamin D: Its role and uses in immunology. FASEB J 15, 25792585.
  • Destefano, A. L., Lew, M. F., Golbe, L. I., Mark, M. H., Lazzarini, A. M., Guttman, M., Montgomery, E., Waters, C. H., Singer, C., Watts, R. L., Currie, L. J., Wooten, G. F., Maher, N. E., Wilk, J. B., Sullivan, K. M., Slater, K. M., Saint-Hilaire, M. H., Feldman, R. G., Suchowersky, O., Lafontaine, A. L., Labelle, N., Growdon, J. H., Vieregge, P., Pramstaller, P. P., Klein, C., Hubble, J. P., Reider, C. R., Stacy, M., MacDonald, M. E., Gusella, J. F. & Myers, R. H. (2002) PARK3 influences age at onset in Parkinson disease: A genome scan in the GenePD study. Am J Hum Genet 70, 10891095.
  • Destefano, A. L., Latourelle, J., Lew, M. F., Suchowersky, O., Klein, C., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., Watts, R., Guttman, M., Racette, B. A., Perlmutter, J. S., Marlor, L., Shill, H. A., Singer, C., Goldwurm, S., Pezzoli, G., Saint-Hilaire, M. H., Hendricks, A. E., Gower, A., Williamson, S., Nagle, M. W., Wilk, J. B., Massood, T., Huskey, K. W., Baker, K. B., Itin, I., Litvan, I., Nicholson, G., Corbett, A., Nance, M., Drasby, E., Isaacson, S., Burn, D. J., Chinnery, P. F., Pramstaller, P. P., Al-Hinti, J., Moller, A. T., Ostergaard, K., Sherman, S. J., Roxburgh, R., Snow, B., Slevin, J. T., Cambi, F., Gusella, J. F. & Myers, R. H. (2008) Replication of association between ELAVL4 and Parkinson disease: The GenePD study. Hum Genet 124, 9599.
  • Edwards, T. L., Lewis, K., Velez, D. R., Dudek, S. & Ritchie, M. D. (2009) Exploring the performance of multifactor dimensionality reduction in large scale SNP studies and in the presence of genetic heterogeneity among epistatic disease models. Hum Hered 67, 183192.
  • Edwards, T. L., Scott, W. K., Almonte, C., Burt, A., Powell, E. H., Beecham, G. W., Wang, L., Zuchner, S., Konidari, I., Wang, G., Singer, C., Nahab, F., Scott, B., Stajich, J. M., Pericak-Vance, M., Haines, J., Vance, J. M. & Martin, E. R. (2010) Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Annals of Hum Genet 74, 97109.
  • Evans, R. M. (1988) The steroid and thyroid hormone receptor superfamily. Science 240, 889895.
  • Evatt, M. L., Delong, M. R., Khazai, N., Rosen, A., Triche, S. & Tangpricha, V. (2008) Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 65, 13481352.
  • Eyles, D. W., Smith, S., Kinobe, R., Hewison, M. & McGrath, J. J. (2005) Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 29, 2130.
  • Ferrari, G., Cusella-De Angelis, G., Coletta, M., Paolucci, E., Stornaiuolo, A., Cossu, G. & Mavilio, F. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279, 15281530.
  • Gao, X., Starmer, J. & Martin, E. R. (2008) A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 32, 361369.
  • Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F. & Wion, D. (2002) New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 13, 100105.
  • Gash, D. M., Zhang, Z., Ovadia, A., Cass, W. A., Yi, A., Simmerman, L., Russell, D., Martin, D., Lapchak, P. A., Collins, F., Hoffer, B. J. & Gerhardt, G. A. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252255.
  • Gezen-Ak, D., Dursun, E., Ertan, T., Hanagasi, H., Gurvit, H., Emre, M., Eker, E., Ozturk, M., Engin, F. & Yilmazer, S. (2007) Association between vitamin D receptor gene polymorphism and Alzheimer's disease. Tohoku J Exp Med 212, 275282.
  • Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N. & Heywood, P. (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 9, 589595.
  • Hancock, D. B., Martin, E. R., Fujiwara, K., Stacy, M. A., Scott, B. L., Stajich, J. M., Jewett, R., Li, Y. J., Hauser, M. A., Vance, J. M. & Scott, W. K. (2006) NOS2A and the modulating effect of cigarette smoking in Parkinson's disease. Ann Neurol 60, 366373.
  • Hancock, D. B., Martin, E. R., Vance, J. M. & Scott, W. K. (2008) Nitric oxide synthase genes and their interactions with environmental factors in Parkinson's disease. Neurogenetics 9, 249262.
  • Horne, B. D., Camp, N. J., Anderson, J. L., Mower, C. P., Clarke, J. L., Kolek, M. J., Carlquist, J. F. & Intermountain Heart Collaborative Study Group (2007) Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease. J Am Coll Cardiol 49, 20532060.
  • Kim, J. S., Kim, Y. I., Song, C., Yoon, I., Park, J. W., Choi, Y. B., Kim, H. T. & Lee, K. S. (2005) Association of vitamin D receptor gene polymorphism and Parkinson's disease in Koreans. J Korean Med Sci 20, 495498.
  • Knekt, P., Kilkkinen, A., Rissanen, H., Marniemi, J., Saaksjarvi, K. & Heliovaara, M. (2010) Serum vitamin D and the risk of Parkinson disease. Arch Neurol 67, 808811.
  • Kordower, J. H., Emborg, M. E., Bloch, J., Ma, S. Y., Chu, Y., Leventhal, L., McBride, J., Chen, E. Y., Palfi, S., Roitberg, B. Z., Brown, W. D., Holden, J. E., Pyzalski, R., Taylor, M. D., Carvey, P., Ling, Z., Trono, D., Hantraye, P., Deglon, N. & Aebischer, P. (2000) Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290, 767773.
  • Latourelle, J. C., Pankratz, N., Dumitriu, A., Wilk, J. B., Goldwurm, S., Pezzoli, G., Mariani, C. B., DeStefano, A. L., Halter, C., Gusella, J. F., Nichols, W. C., Myers, R. H., Foroud, T., PROGENI Investigators, Coordinators and Molecular Genetic Laboratories & GenePD Investigators, Coordinators and Molecular Genetic Laboratories (2009) Genomewide association study for onset age in Parkinson disease. BMC medical genetics 10, 98.
  • Li, Y., Oliveira, S., Xu, P., Martin, E., Stenger, J., Hulette, C., Scherzer, C., Hauser, M., Scott, W., Small, G., Nance, M., Watts, R., Hubble, J., Koller, W., Pahwa, R., Stern, M., Hiner, B., Jancovic, J., Goetz, C., Mastaglia, F., Middleton, L., Roses, A., Saunders, A., Welsh-Bohmer, K., Schmechel, D., Gullans, S., Haines, J., Gilbert, J., Vance, J. & Pericak-Vance, M. (2003) Glutathione S-transferase modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 24, 32593267.
  • Li, Y., Oliveira, S. A., Xu, P., Martin, E. R., Stenger, J. E., Scherzer, C. A., Hulette, C., Scott, W. K., Small, G. W., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., Stern, M. B., Hiner, B. C., Jankovic, J., Goetz, C. G., Mastaglia, F., Middleton, L. T., Roses, A. D., Saunders, A. M., Welsh-Bohmer, K. A., Schmechel, D. E., Gullans, S. R., Haines, J. L., Gilbert, J. R., Vance, J. M. & Pericak-Vance, M. A. (2003) Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum Mol Genet 12, 32593267.
  • Li, Y., Schrodi, S., Rowland, C., Tacey, K., Catanese, J. & Grupe, A. (2006) Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease. Hum Mutat 27, 10171023.
  • Li, Y., Scott, W. K., Hedges, D. J., Zhang, F., Gaskell, P. C., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Pahwa, R., Stern, M. B., Hiner, B. C., Jankovic, J., Allen, F. A., Jr., Goetz, C. G., Mastaglia, F., Stajich, J. M., Gibson, R. A., Middleton, L. T., Saunders, A. M., Scott, B. L., Small, G. W., Nicodemus, K. K., Reed, A. D., Schmechel, D. E., Welsh-Bohmer, K. A., Conneally, P. M., Roses, A. D., Gilbert, J. R., Vance, J. M., Haines, J. L. & Pericak-Vance, M. A. (2002) Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70, 985993.
  • MA, N., Qin X-J., SA, O., TA, S., Van Der Walt J. M., MA, H., Pericak-Vance, M.A. & JM, V. (2005) Association between the neuron-specific RNA-binding protein ELAVL4 and Parkinson disease. Hum Genet 117, 2733.
  • Maher, N. E., Golbe, L. I., Lazzarini, A. M., Mark, M. H., Currie, L. J., Wooten, G. F., Saint-Hilaire, M., Wilk, J. B., Volcjak, J., Maher, J. E., Feldman, R. G., Guttman, M., Lew, M., Schuman, S., Suchowersky, O., Lafontaine, A. L., Labelle, N., Vieregge, P., Pramstaller, P. P., Klein, C., Hubble, J., Reider, C., Growdon, J., Watts, R., Montgomery, E., Baker, K., Singer, C., Stacy, M. & Myers, R. H. (2002) Epidemiologic study of 203 sibling pairs with Parkinson's disease: The GenePD study. Neurology 58, 7984.
  • Mamutse, G., Woolmore, J., Pye, E., Partridge, J., Boggild, M., Young, C., Fryer, A., Hoban, P. R., Rukin, N., Alldersea, J., Strange, R. C. & Hawkins, C. P. (2008) Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis. Mult Scler 14, 12801283.
  • Maraganore, D. M., de Andrade, M., Elbaz, A., Farrer, M. J., Ioannidis, J. P., Kruger, R., Rocca, W. A., Schneider, N. K., Lesnick, T. G., Lincoln, S. J., Hulihan, M. M., Aasly, J. O., Ashizawa, T., Chartier-Harlin, M. C., Checkoway, H., Ferrarese, C., Hadjigeorgiou, G., Hattori, N., Kawakami, H., Lambert, J. C., Lynch, T., Mellick, G. D., Papapetropoulos, S., Parsian, A., Quattrone, A., Riess, O., Tan, E. K., Van Broeckhoven, C. & Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium (2006) Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 296, 661670.
  • Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39, 906913.
  • Martin, E. R., Monks, S. A., Warren, L. L. & Kaplan, N. L. (2000) A test for linkage and association in general pedigrees: The pedigree disequilibrium test. Am J Hum Genet 67, 146154.
  • McCulloch, C. C., Kay, D. M., Factor, S. A., Samii, A., Nutt, J. G., Higgins, D. S., Griffith, A., Roberts, J. W., Leis, B. C., Montimurro, J. S., Zabetian, C. P. & Payami, H. (2008) Exploring gene-environment interactions in Parkinson's disease. Hum Genet 123, 257265.
  • McDonnell, S. K., Schaid, D. J., Elbaz, A., Strain, K. J., Bower, J. H., Ahlskog, J. E., Maraganore, D. M. & Rocca, W. A. (2006) Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study. Ann Neurol 59, 788795.
  • Mizuta, I., Satake, W., Nakabayashi, Y., Ito, C., Suzuki, S., Momose, Y., Nagai, Y., Oka, A., Inoko, H., Fukae, J., Saito, Y., Sawabe, M., Murayama, S., Yamamoto, M., Hattori, N., Murata, M. & Toda, T. (2006) Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum Molec Genet 15, 11511158.
  • Mizuta, I., Tsunoda, T., Satake, W., Nakabayashi, Y., Watanabe, M., Takeda, A., Hasegawa, K., Nakashima, K., Yamamoto, M., Hattori, N., Murata, M. & Toda, T. (2008) Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease. Hum Genet 124, 8994.
  • Monks, S. A. & Kaplan, N. L. (2000) Removing the sampling restrictions from family-based tests of association for a quantitative-trait locus. Am J Hum Genet 66, 576592.
  • Moonesinghe, R., Khoury, M. J. & Janssens, A. C. (2007) Most published research findings are false-but a little replication goes a long way. PLoS med 4, e28.
  • Naveilhan, P., Neveu, I., Wion, D. & Brachet, P. (1996) 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 7, 21712175.
  • Niino, M., Fukazawa, T., Yabe, I., Kikuchi, S., Sasaki, H. & Tashiro, K. (2000) Vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci 177, 6571.
  • Oliveira, S. A., Li, Y. J., Noureddine, M. A., Zuchner, S., Qin, X., Pericak-Vance, M. A. & Vance, J. M. (2005) Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease. Am J Hum Genet 77, 252264.
  • Oliveira, S. A., Scott, W. K., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Lyons, K. E., Pahwa, R., Stern, M. B., Hiner, B. C., Jankovic, J., Ondo, W. G., Allen, F. H., Jr., Scott, B. L., Goetz, C. G., Small, G. W., Mastaglia, F. L., Stajich, J. M., Zhang, F., Booze, M. W., Reaves, J. A., Middleton, L. T., Haines, J. L., Pericak-Vance, M. A., Vance, J. M. & Martin, E. R. (2003) Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol 60, 975980.
  • Partridge, J. M., Weatherby, S. J., Woolmore, J. A., Highland, D. J., Fryer, A. A., Mann, C. L., Boggild, M. D., Ollier, W. E., Strange, R. C. & Hawkins, C. P. (2004) Susceptibility and outcome in MS: Associations with polymorphisms in pigmentation-related genes. Neurology 62, 23232325.
  • Ponsonby, A. L., Pezic, A., Ellis, J., Morley, R., Cameron, F., Carlin, J. & Dwyer, T. (2008) Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: A meta-regression analysis. Am J Epidemiol 168, 358365.
  • Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., Maller, J., Sklar, P., de Bakker, P. I., Daly, M. J. & Sham, P. C. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559575.
  • Sato, Y., Honda, Y., Iwamoto, J., Kanoko, T. & Satoh, K. (2005) Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients. Mov Disord 20, 15981603.
  • Sato, Y., Kikuyama, M. & Oizumi, K. (1997) High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 49, 12731278.
  • Scherzer, C. R., Eklund, A. C., Morse, L. J., Liao, Z., Locascio, J. J., Fefer, D., Schwarzschild, M. A., Schlossmacher, M. G., Hauser, M. A., Vance, J. M., Sudarsky, L. R., Standaert, D. G., Growdon, J. H., Jensen, R. V. & Gullans, S. R. (2007) Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A 104, 955960.
  • Schrauwen, I., Ealy, M., Huentelman, M. J., Thys, M., Homer, N., Vanderstraeten, K., Fransen, E., Corneveaux, J. J., Craig, D. W., Claustres, M., Cremers, C. W., Dhooge, I., Van de Heyning, P., Vincent, R., Offeciers, E., Smith, R. J. & Van Camp, G. (2009) A genome-wide analysis identifies genetic variants in the RELN gene associated with otosclerosis. Am J Hum Genet 84, 328338.
  • Smith, M. P., Fletcher-Turner, A., Yurek, D. M. & Cass, W. A. (2006) Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res 31, 533539.
  • Smolders, J., Peelen, E., Thewissen, M., Menheere, P., Cohen Tervaert, J. W., Hupperts, R. & Damoiseaux, J. (2009) The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 8, 621626.
  • Tajouri, L., Ovcaric, M., Curtain, R., Johnson, M. P., Griffiths, L. R., Csurhes, P., Pender, M. P. & Lea, R. A. (2005) Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet 19, 2538.
  • Thomas, B. & Beal, M. F. (2007) Parkinson's disease. Hum Molec Genet 16, R183R194.
  • Uitterlinden, A. G., Fang, Y., Van Meurs, J. B., Pols, H. A. & Van Leeuwen, J. P. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338, 143156.
  • Van Der Walt, J. M., Noureddine, M. A., Kittappa, R., Hauser, M. A., Scott, W. K., McKay, R., Zhang, F., Stajich, J. M., Fujiwara, K., Scott, B. L., Pericak-Vance, M. A., Vance, J. M. & Martin, E. R. (2004) Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. Am J Hum Genet 74, 11211127.
  • Wahner, A. D., Sinsheimer, J. S., Bronstein, J. M. & Ritz, B. (2007) Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease. Arch Neurol 64, 836840.
  • Wang, L., Hauser, E. R., Shah, S. H., Seo, D., Sivashanmugam, P., Exum, S. T., Gregory, S. G., Granger, C. B., Haines, J. L., Jones, C. J., Crossman, D., Haynes, C., Kraus, W. E., Freedman, N. J., Pericak-Vance, M. A., Goldschmidt-Clermont, P. J. & Vance, J. M. (2008a) Polymorphisms of the tumor suppressor gene LSAMP are associated with left main coronary artery disease. Ann Hum Genet 72, 443453.
  • Wang, G., Van Der Walt, J. M., Mayhew, G. M., Li, Y., Zuchner, S., Scott, W. K., Martin, E. R. & Vance, J. M. (2008b) Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by over-expression of α-synuclein. Am J Hum Genet 82, 283289.
  • Wang, J. Y., Wu, J. N., Cherng, T. L., Hoffer, B. J., Chen, H. H., Borlongan, C. V. & Wang, Y. (2001) Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain research 904, 6775.
  • Winkler, S., Hagenah, J., Lincoln, S., Heckman, M., Haugarvoll, K., Lohmann-Hedrich, K., Kostic, V., Farrer, M. & Klein, C. (2007) alpha-Synuclein and Parkinson disease susceptibility. Neurology 69, 17451750.